We demonstrated the downregulation of IFITM10, CH25H, NCR3, and KLRK1 and the upregulation of ID1 in the PBMCs from RTP patients compared with that from patients with moderate or severe COVID-19 (Supplementary Figure S4B and C). This evidence concerns the gene NCR3 and COVID-19.